No Prescription |
 |
 | ||
|
HIPRESS Tenormin |
|
| ||
No Prescription » Prescription Drugs 8 » HIPRESS Tenormin Atenolol is used alone or in combination with other medications to treat high blood pressure. It also is used to prevent angina (chest pain) and treat heart attacks. Atenolol is in a class of medications called beta blockers. It works by slowing the heart rate and relaxing the blood vessels so the heart does not have to pump as hard.Atenolol comes as a tablet to take by mouth. It is usually taken once or twice a day. To help you remember to take atenolol take it around the same time every day. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take atenolol exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Atenolol controls high blood pressure and angina but does not cure them. It may take 1-2 weeks before you feel the full benefit of atenolol. Continue to take atenolol even if you feel well. Do not stop taking atenolol without talking to your doctor.Atenolol is also used sometimes to prevent migraine headaches and to treat alcohol withdrawal heart failure and irregular heartbeat. Talk to your doctor about the possible risks of using this medication for your condition. Buy HIPRESS Tenormin and other Prescription Drugs 8 products online at Medstore. Buy Online at Medstore - Click Here!
About HIPRESS Tenormin: Product Type: Prescription Drugs 8 HIPRESS ( Tenormin Generic Atenolol ) HIPRESS (Tenormin Generic Atenolol) Tenormin Generic Atenolol 100mg Tabs 25mg Tabs 50mg Tabs 28 (2 x 14) Tenormin Generic Atenolol HIPRESS
View more Prescription Drugs 8 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
